Moderna

EMA states two doses of anti-COVID vaccines are necessary for adequate protection against the Delta variant. Emphasis on accelerating vaccination campaigns and ordering additional doses to prevent new variant emergence. Combination of two doses from different manufacturers deemed safe and effective. Early to determine future need for additional doses due to insufficient data on vaccine protection duration.

Researchers from the University of Chicago developed a new approach to identify snoRNA targets, revealing thousands of previously unknown interactions in human cells and mouse brain tissues. These interactions include functions beyond rRNA modifications, such as facilitating protein secretion, which could be harnessed for therapeutic and biotechnology applications. The study, published in Cell, suggests a broader role for snoRNAs in cellular processes and opens new avenues for research and potential therapeutics.

Israeli and Portuguese scientists developed a Covid-19 nano-vaccine stored at room temp, administered as a nasal spray, effective against all variants, and potentially paving the way for simpler, more affordable vaccines.

ChatGPT, OpenAI's AI chatbot, has seen rapid growth and expanded partnerships, including with Apple for Apple Intelligence. OpenAI faces challenges such as internal departures, copyright lawsuits, and ethical concerns, including a voice mimicking Scarlett Johansson. GPT-4o, OpenAI's latest model, offers voice capabilities but faces controversies. OpenAI continues to innovate with features like Advanced Voice Mode and SearchGPT, while addressing regulatory and ethical issues.

Researchers at the University of Chicago developed a technology to identify new cellular RNA targets of snoRNAs, revealing thousands of previously unknown targets in human cells and mouse brain tissues, including interactions with mRNA that facilitate protein secretion, with potential applications in therapeutics and biotechnology.

Innovations in obesity, ovarian cancer vaccines, Alzheimer’s, and mental health drugs are transforming healthcare, with UK tech stocks and biotech sectors offering untapped investment opportunities. Key players include Intra-Cellular Therapies, Supernus Pharmaceuticals, and specialist providers like Bioventix and Diaceutics. Funds like Comgest Growth Europe ex UK and Polar Capital Global Healthcare Trust offer diversified healthcare exposure.

MSD reported positive Phase III MK-3475A-D77 trial results, showing noninferiority of subcutaneous Keytruda (pembrolizumab) with chemotherapy for metastatic NSCLC, meeting pharmacokinetic endpoints and demonstrating steady efficacy and safety.

Ampersand Biomedicines and Montai Therapeutics collaborate with Pfizer to identify potential treatments for obesity and non-small cell lung cancer, leveraging their respective AND™ and CONECTA™ AI platforms.

Biotechnology Market to grow at 13.9% CAGR from 2024-2031, driven by health, agriculture, and industrial applications. Valued at USD 1.21 Trillion in 2022, it is expected to reach USD 3.90 Trillion by 2031.